Let’s Partner Together
Leica Biosystems partners with clinicians and laboratory professionals to help achieve breakthrough speed with complete confidence in their results.
What's New
Leica Biosystems strives to help our customers reach their objectives by connecting departments, solutions, and processes across the cancer diagnosis pathway.
If you missed the NSH Virtual tradeshow or did not get a chance to visit our booth, we are pleased to share all the presentations that were featured at the show.
The world’s first tissue processor that provides you with the high quality tissue processing you trust, and with added Track and Trace features and Density meter to reduce potential errors in your lab.
Watch this fascinating webcast on digital pathology in the time of COVID-19 and glean knowledge from questions asked by your colleagues and answered by pathologists.
Leica Biosystems continues to expand the BOND menu introducing both new and improved antibodies. Take advantage of this special offer to evaluate up to 5 Ready to Use Antibodies for only $99 USD* each. Try now with the offer code 99RTU20 on our eCommerce page.
Leica Biosystems is introducing five new immuno-oncology (IO) markers in a BOND Ready-to-Use format to complement the IO menu and two new clinical diagnostic antibodies for the BOND Ready-to-Use portfolio augmenting the Lung and Gastrointestinal pathology menus.